Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/03/2009US20090298872 Compounds and compositions as modulators of steroidal receptors and calcium channel activities
12/03/2009US20090298871 Sulfonyl-phenyl-2h-[1,2,4]oxadiazol-5-one derivatives , processes for their preparation and their use as pharmaceuticals
12/03/2009US20090298870 Podophyllotoxin derivatives
12/03/2009US20090298869 Crystalline pharmaceutical and methods of preparation and use thereof
12/03/2009US20090298868 Quinoline compounds as melanogenesis modifiers and uses thereof
12/03/2009US20090298867 Tricyclic delta-opioid modulators
12/03/2009US20090298866 Indole Compounds
12/03/2009US20090298865 Derivatives of pyrrolopyridine-2-carboxamides, preparation thereof and therapeutic application thereof
12/03/2009US20090298864 Methods for Treating Mild Cognitive Impairment
12/03/2009US20090298863 Administration of tlr7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus
12/03/2009US20090298862 Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition
12/03/2009US20090298861 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
12/03/2009US20090298858 Potent parp inhibitors
12/03/2009US20090298857 Treatment of Neurodegenerative Diseases Through Inhibition of HSP90
12/03/2009US20090298856 2,3 Substituted fused bicyclic pyrimidin-4(3H)-ones modulating the function of the vanilliod-1receptor (VR1)
12/03/2009US20090298855 Protein Tyrosine Kinase Inhibitors
12/03/2009US20090298854 Indole acetic acid derivatives and their use as pharmaceutical agents
12/03/2009US20090298853 Carbamoyl Compounds as DGAT1 Inhibitors 190
12/03/2009US20090298852 Pellet-form slow-release preparation for vertigo
12/03/2009US20090298851 Phenyl piperazine compounds, pharmaceutical composition comprising the same and use thereof
12/03/2009US20090298850 Treatment for Neurological and Mental Disorders
12/03/2009US20090298849 Materials and Methods Relating to the Induction of Apoptosis in Target Cells
12/03/2009US20090298848 Methods and Compositions for Treating Barth Syndrome, Cardiomyopathy, Mitochondrial Diseases and Other Conditions
12/03/2009US20090298847 Manufacturing method of solid dispersion containing itraconazole
12/03/2009US20090298846 such as 6-[2-(4-Hydroxyphenyl)ethylamino]-11H-indolo[3,2-c]quinoline, used to inhibit both growth of cancer cells and activity of telomerase
12/03/2009US20090298845 Piperazinyl derivatives as modulators of chemokine receptor activity
12/03/2009US20090298844 Abl kinase inhibition
12/03/2009US20090298843 Treatment of hematological malignancies with fts and a bcr-abl tyrosine kinase inhibitor
12/03/2009US20090298842 Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
12/03/2009US20090298841 serotonin receptor modulators such as 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline, used for treating obesity, nervous system disorders such as dementia, schizophrenia and Alzheimer's disease, and as cognition activators
12/03/2009US20090298840 Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
12/03/2009US20090298839 Adrb2 gene polymorphism associated with intraocular pressure response to topical beta-blockers
12/03/2009US20090298838 Method for Determination of Effective Dose of Methotrexate
12/03/2009US20090298837 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis
12/03/2009US20090298836 Thiadiazole modulators of PKB
12/03/2009US20090298835 Novel scaffolds for alpha-helix mimicry
12/03/2009US20090298834 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/03/2009US20090298833 Piperidinyl derivatives as modulators of chemokine receptor activity
12/03/2009US20090298832 Trisubstituted thiazole compounds, preparations methods, pharmaceutical compositions and medicals uses thereof
12/03/2009US20090298831 Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
12/03/2009US20090298830 4-Aryl-2-Amino-Pyrimidnes or 4-Aryl-2-Aminoalkyl-Pyrimidines as Jak-2 Modulators and Methods of Use
12/03/2009US20090298829 Melanocortin receptor agonists
12/03/2009US20090298827 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
12/03/2009US20090298826 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
12/03/2009US20090298825 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
12/03/2009US20090298824 Organic compounds
12/03/2009US20090298823 Inhibitors of protein kinases
12/03/2009US20090298822 Use of Activators of Soluble Guanylate Cyclase for Treating Reperfusion Damage
12/03/2009US20090298821 Hydroxy and alkoxy substituted ih-imidazonaphthyridines and methods
12/03/2009US20090298820 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/03/2009US20090298819 Compositions, Synthesis, And Methods Of Using Piperazine Based Antipsychotic Agents
12/03/2009US20090298818 Pharmaceutical compounds
12/03/2009US20090298817 Anti-amnesic compounds and pharmaceutical compositions comprising them
12/03/2009US20090298816 Pesticides containing a bicyclic bisamide structure
12/03/2009US20090298815 Benzene Sulfonamide Thiazole and Oxazole Compounds
12/03/2009US20090298814 Novel salts of conjugated psychotropic drugs and processes of preparing same
12/03/2009US20090298813 Use of neuroprotective compounds in obtaining medicaments intended for the treatment of neurodegenerating diseases
12/03/2009US20090298812 Substituted Sulfonamide Compounds
12/03/2009US20090298811 Benzimidazolone derivatives
12/03/2009US20090298810 IL-8 Receptor Antagonists
12/03/2009US20090298809 5-ht3 receptor modulators, methods of making, and use thereof
12/03/2009US20090298808 Inhibitors of 11-beta hydroxyl steroid dehydrogenase type i and methods of using the same
12/03/2009US20090298807 Compounds
12/03/2009US20090298806 Factor xa inhibitors
12/03/2009US20090298805 Topical pyrithione compositions and methods for treatment of nail fungus
12/03/2009US20090298804 Novel Compounds and Methods for Their Production
12/03/2009US20090298803 Pharmaceutical composition comprising fluocinonide
12/03/2009US20090298802 Pharmaceutical Compositions
12/03/2009US20090298801 Petroleum jelly-free unguent compositions comprising vitamin D compounds and optionally steroidal anti-inflammatory agents
12/03/2009US20090298800 1,25-dihydroxy, 20-cyclopropyl,26-27-deuteroalkyl vitamin d3 compounds and methods of use thereof
12/03/2009US20090298799 Methods of Treating Osteoporosis and Secondary Hyperparathyroidism Using 20-Methyl, Gemini Vitamin D3 Compounds
12/03/2009US20090298798 Combinations of adapalene and benzoyl peroxide for treating acne lesions
12/03/2009US20090298797 Combination therapy for the treatment of influenza
12/03/2009US20090298796 Reducing risk of type 2 diabetes (t2d)
12/03/2009US20090298795 Thiol-Sensitive Positive Inotropes
12/03/2009US20090298794 Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists
12/03/2009US20090298793 Acylgycerophospholipids for treating symptoms concomitant with cancer
12/03/2009US20090298792 Anti-Inflammatory Polymer
12/03/2009US20090298791 Combinations comprising epothilones and antimetabolites
12/03/2009US20090298790 Novel therapeutic use for treating of leukemia
12/03/2009US20090298789 arresting heart of subject in need of heart surgery by exposing heart to effective amounts of a compound chosen from a potassium channel opener, a potassium channel agonist, an adenosine receptor agonist, and a local anaesthetic under conditions sufficient for heart to be arrested
12/03/2009US20090298788 5-[6-Amino-2-(2-hydroxy-adamantan-2-ylethynyl)-purin-9-yl]-3,4-dihydroxy-tetrahydro-furan-2-carboxylic acid cyclopropylamide for the treatment of inflammatory activity in mammalian tissue; A2A adenosine receptor agonist; autoimmune stimulation, allergic diseases, skin diseases, infectious diseases
12/03/2009US20090298787 Dsrna as Insect Control Agent
12/03/2009US20090298786 Methods of treating viral infections with anthracycline antibiotics
12/03/2009US20090298785 Method for Treating Ocular Cancer
12/03/2009US20090298784 Isolation and structure of turbostatins 1-4
12/03/2009US20090298783 Cosmetic Compositions
12/03/2009US20090298782 Compounds for Delivering Amino Acids or Peptides with Antioxidant Activity into Mitochondria and Use Thereof
12/03/2009US20090298771 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
12/03/2009US20090298766 Detection and treatment of cancers
12/03/2009US20090298763 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
12/03/2009US20090298760 Modified Coagulation Factor VIIa With Extended Half-Life
12/03/2009US20090298754 Hai-1 and hai-2 in cancer therapy
12/03/2009US20090298752 Aplidine treatment of cancers
12/03/2009US20090298748 Methods of administering dalbavancin for treatment of bacterial infections
12/03/2009US20090298745 Treatment of Diabetes with Glycogen Phosphorylase Inhibitors
12/03/2009US20090298744 Heterocyclic compounds as adenosine receptor antagonist
12/03/2009US20090298743 Hydrophobic compositions containing reconstitution enhancer
12/03/2009US20090298742 Process for manufacturing lactose
12/03/2009US20090298740 Novel nucleotide sequences
1 ... 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 ... 7860